These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 30571177)

  • 21. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
    Zhao N; Li CC; Di B; Xu LL
    J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
    Tang T; Gong T; Jiang W; Zhou R
    Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the NLRP3 inflammasome in psoriasis.
    Chen X; Deng G; Chen K; Chen Y; Ye W; Sun P
    Int J Dermatol; 2024 Jul; 63(7):844-851. PubMed ID: 38345734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammasome as a New Therapeutic Target for Diabetic Complications.
    Volpe CM; Anjos PM; Nogueira-Machado JA
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of NLRP3 inflammasome in inflammatory bowel diseases.
    Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
    World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
    Maayah ZH; Takahara S; Dyck JRB
    Arch Toxicol; 2021 Jan; 95(1):1-9. PubMed ID: 32852568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases.
    Wang D; Duncan B; Li X; Shi J
    J Dermatol Sci; 2020 Jun; 98(3):146-151. PubMed ID: 32173167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosmarinic acid inhibits nicotine-induced C-reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cells.
    Yao Y; Mao J; Xu S; Zhao L; Long L; Chen L; Li D; Lu S
    J Cell Physiol; 2019 Feb; 234(2):1758-1767. PubMed ID: 30146678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
    Özenver N; Efferth T
    Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis.
    Ferrero-Andrés A; Panisello-Roselló A; Roselló-Catafau J; Folch-Puy E
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.
    Vong CT; Tseng HHL; Yao P; Yu H; Wang S; Zhong Z; Wang Y
    Drug Discov Today; 2021 Jun; 26(6):1394-1408. PubMed ID: 33636340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Effects and Mechanisms of Chinese Medicines Modulating NLRP3 Inflammasomes in Ischemic Cardio/Cerebral Vascular Disease.
    Li Y; Liu Y; Yan X; Liu Q; Zhao YH; Wang DW
    Am J Chin Med; 2018; 46(8):1727-1741. PubMed ID: 30525898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immunity as a target for acute cardioprotection.
    Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
    Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms regulating NLRP3 inflammasome activation.
    Jo EK; Kim JK; Shin DM; Sasakawa C
    Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinones as preventive agents in Alzheimer's diseases: focus on NLRP3 inflammasomes.
    Chen DB; Gao HW; Peng C; Pei SQ; Dai AR; Yu XT; Zhou P; Wang Y; Cai B
    J Pharm Pharmacol; 2020 Nov; 72(11):1481-1490. PubMed ID: 32667050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of NLRP3 inflammasome attenuates spinal cord injury-induced lung injury in mice.
    Jiang W; Li M; He F; Zhu L
    J Cell Physiol; 2019 May; 234(5):6012-6022. PubMed ID: 30589073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.
    Segovia JA; Chang TH; Winter VT; Coalson JJ; Cagle MP; Pandranki L; Bose S; Baseman JB; Kannan TR
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061706
    [No Abstract]   [Full Text] [Related]  

  • 39. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
    Jiang H; Gong T; Zhou R
    Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance.
    Zhang X; Qu H; Yang T; Kong X; Zhou H
    Biomed Pharmacother; 2021 Nov; 143():112219. PubMed ID: 34560540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.